People with type 2 diabetes face a higher severe dengue risk, according to a new study. Researchers found the condition can increase the chances of dangerous dengue complications.
The US Cancer Market has moved a step closer for Alembic Pharma and Natco Pharma after the companies secured a key regulatory milestone.
Novo Nordisk’s Wegovy gains CDSCO approval for MASH in India, marking a key GLP-1 expansion into liver disease, strengthening its role in metabolic disorder treatment.
A wave of strategic deals, policy momentum, and technological breakthroughs defined the week for India’s drug manufacturers
A recent drug recall involving oncology products has once again brought global pharmaceutical quality standards into focus, recalls are not necessarily indicators of systemic failure but rather evidence of active monitoring and corrective mechanisms
The suspension of Premarin vaginal cream by Pfizer has drawn attention for its immediate impact, and also signals in evolving priorities in the Indian market
Merck’s cholesterol pill is poised to reshape the global cardiovascular drug landscape, this comes with the latest approval from the U.S. Food and Drug Administration for its first-in-class oral PCSK9 inhibitor
India’s pharmaceutical sector is entering a transformative phase with AI and biologics powering the pharma innovation that will reshaping the industry’s future
The hidden ingredient powering the world’s next TB vaccine is not the antigen itself. But a highly specialized immune-boosting component known as the AS01E adjuvant
The fight against tuberculosis is no longer just about better medicines or advanced diagnostics, rather, it is increasingly about speed
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")